The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
New PhD in Perinatal Pharmacopidemiology!
Sep. 30, 2021 4:59 PM
PharmaTox PhD student Sarah Hjorth Andersen has defended her doctoral thesis "Childhood outcomes after prenatal exposure to analgesics or antibiotics". Congratulations!
New master's thesis!
Aug. 19, 2021 4:30 PM
Ingliv Gjetmundsen defended her master's thesis in June 2021. Congratulations!
Ny PharmaSafe-artikkel publisert!
Aug. 11, 2021 10:26 PM
Ny artikkel fra PharmaSafe oppsummerer hva vi vet om medisinbruk i svangerskapet og risiko for barnekreft.
Welcome, Mostafa Alwash!
Aug. 6, 2021 10:03 PM
We welcome Mostafa Alwash as a new postdoc of PharmaTox. He presents himself below.
New article from PharmaTox summarises the research on prenatal medication exposure and offspring epigenetic outcomes
June 22, 2021 8:38 PM